Ebell said that Brandt had relationships with pharmaceutical companies.
Brandt had a different view. "I don't have any ties to industry that would have any relevance to this publication," he said. "I don't receive money directly from any company. I own no stock and, nor does my family, so this is a totally unbiased thing. I have no conflict of interest whatsoever, and I think that does it."
The American College of Gastroenterology said: "No company was involved in any way in either structuring or completing the meta-analysis that forms the basis for the College's evidence-based recommendations on IBS. Furthermore, no company was in any way involved in deciding who served on the Task Force or in any of its work."
To learn more about IBS, visit the U.S. National Institute of Diabetes and Digestive and Kidney Diseases online.
Copyright © 2011 HealthDay. All rights reserved.